𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1

✍ Scribed by Britschgi, C; Rizzi, M; Grob, T J; Tschan, M P; Hügli, B; Reddy, V A; Andres, A-C; Torbett, B E; Tobler, A; Fey, M F

Book ID
110070271
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
210 KB
Volume
25
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allelic methylation bias of the RARB2 tu
Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer
✍ Jane J. Pappas; André Toulouse; Josée Hébert; Raouf Fetni; W. E. C. Bradley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB

## Abstract Retinoic acid receptor B2 (__RARB2__) is frequently inactivated in cancer. Methylation in the 5′‐untranslated region and first exon is known to play a role; however, few studies have analyzed the detailed methylation pattern of the promoter region. We show that hypo‐ and hypermethylated

Promoter hypermethylation of the potenti
Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma
✍ Daisuke Yamada; Shinji Kikuchi; Yuko N. Williams; Mika Sakurai-Yageta; Mari Masu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 801 KB

## Abstract Renal clear cell carcinoma (RCCC) is a malignant tumor with poor prognosis caused by the high incidence of metastasis to distal organs. Although metastatic RCCC cells frequently show aberrant cytoskeletal organization, the underlying mechanism has not been elucidated. DAL‐1/4.1B is an a

Prevalence of serum antibodies against t
Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
✍ Katerina Angelopoulou; Eleftherios P. Diamandis; Donald J. A. Sutherland; John A 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 808 KB

## Abstract We have developed 2 new quantitative methods for measuring anti‐p53 antibodies in human serum. Using these methods we analyzed 1,392 sera from patients with various malignancies and 230 sera from individuals without malignancy. Highest prevalence of anti‐p53 antibodies was associated wi